Charles River Laboratories

Charles River Laboratories is a global contract research organization (CRO) and contract development and manufacturing organization (CDMO) that supports the full drug discovery and development continuum. The company provides a wide range of products, models, services, and guidance tailored to specific client needs across basic research, early-stage development, and safe manufacture of novel drugs and therapeutics.

Key Service Areas:

• Basic research with expansive selection of research animal models and human-derived products
• Management of genetically modified models and health surveillance
• Clinical trial support and preclinical research
• Regulatory support and CMC services
• Manufacturing and scale-up capabilities

Global Presence: Strategically located facilities across North America, Europe, and Asia with experienced teams equipped to handle diverse projects. The organization emphasizes local expertise combined with global reach to provide personalized service tailored to unique regional and regulatory requirements.

Track Record:

• 80% of FDA-approved drugs over the past five years involved Charles River
• 1,500 IND studies supported in the last 12 months
• 100 IND submissions containing Retrogenix® platform data supported across FDA, EMA, and PMDA

Innovation Focus: Committed to developing New Approach Methodologies (NAM) and alternatives to animal testing, including inhalation toxicology test development in partnership with MatTek Corporation.